Valentin Kolev, MD
Gynecologic Oncology · New York, NYNPI 1700070380
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,734 of the $22,615 with a category attached, or 74.0%. Covidien LP accounts for 85.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $19,817 and has fallen 99.9% since, to $19 in 2025. Among gynecologic oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $426.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$19K
- AbbVie$1K
- Gynesonics, Inc.$745
- Intuitive Surgical$727
- Medtronic$650
- AstraZeneca$40
- plus $90 from 3 others
What the payments were for
- Consulting fees$16,73474%
- Travel & lodging$3,10614%
- Food & beverage$2,76212%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 18 | $19,345 |
| AbbVie | 13 | $1,018 |
| Gynesonics, Inc. | 3 | $745 |
| Intuitive Surgical | 13 | $727 |
| Medtronic | 1 | $650 |
| AstraZeneca | 2 | $40 |
| Eisai Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $30 |
| GSK | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,615 in reported general payments places this provider in the 90th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New York
- Bhavana PothuriNew York$366K
- Mario LeitaoNew York$116K
- Konstantin ZakashanskyNew York$93K
- Evelyn CantilloNew York$79K
- Farr NezhatNew York$41K
- Kristen ZeligsNew York$38K
- Nimesh NagarshethNew York$33K
- Jeff LinNew York$30K
- Jason WrightNew York$19K
- Kevin HolcombNew York$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.